Urology · Long Beach, CA
NPI
1366461832
Since 2006
Specialty
Urology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
701 E 28th St, Suite 319
Long Beach, CA, 90806
Phone (562) 595-5977
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
1,891 services
Medicare patients, 2024
422
Average age 73
Drug cost, 2024
$410K
3,178 prescriptions
Company payments, 2025
$1,465
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barton H Wachs was code 99213 (office e&m - established), 499 times for 292 patients. In total Barton H Wachs billed 1,891 services in 65 codes, and Medicare paid $122K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 499 | 292 | $73.11 | $36K |
| 81002 Clinical Chemistry | Office | 417 | 251 | $3.39 | $1,412 |
| 99203 Office E&M - New | Office | 102 | 102 | $85.26 | $8,697 |
| 99211 Office E&M - Established | Office | 58 | 32 | $19.48 | $1,130 |
| 99223 Hospital E&M - Initial | Facility | 49 | 42 | $147.68 | $7,236 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 46 | 12 | $0.36 | $16.63 |
| 52000 Cystourethroscopy | Office | 44 | 38 | $199.09 | $8,760 |
| 99214 Office E&M - Established | Office | 36 | 35 | $104.90 | $3,776 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 28 | 26 | $1.95 | $54.56 |
| 51798 Ultrasound - Nonspecific | Office | 21 | 21 | $9.83 | $206 |
| 52648 Prostate Resection | Facility | 17 | 17 | $587.61 | $9,989 |
| 55700 Other Organ Systems | Office | 14 | 14 | $218.72 | $3,062 |
| 76942 Ultrasound - Nonspecific | Office | 13 | 13 | $52.82 | $687 |
| 76872 Ultrasound - Nonspecific | Office | 12 | 12 | $130.88 | $1,571 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 11 | 11 | $28.74 | $316 |
By year: 2022 $131K for 2,021 services; 2023 $112K for 2,687 services; 2024 $122K for 1,891 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 417 | 251 | $3.39 | $1,412 |
Medicare prescription drug claims, 2024
In 2024, the drug Barton H Wachs prescribed most often to Medicare patients was Terazosin Hcl, with 693 prescriptions and refills. In total Barton H Wachs wrote 3,178 Medicare prescriptions that cost $410K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Terazosin Hcl Generic | 693 | 1,769 | 222 | $12K |
| Tamsulosin Hcl Generic | 486 | 1,345 | 168 | $6,274 |
| Finasteride Generic | 331 | 976 | 117 | $4,868 |
| Myrbetriq Mirabegron | 286 | 481 | 89 | $199K |
| Ciprofloxacin Hcl Generic | 260 | 260 | 201 | $721 |
| Estradiol Generic | 135 | 286 | 69 | $8,809 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 98 | 117 | 39 | $2,332 |
| Bicalutamide Generic | 93 | 209 | 34 | $3,137 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 90 | 91 | 70 | $319 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 89 | 220 | 28 | $2,459 |
| Gemtesa Vibegron | 60 | 112 | 15 | $50K |
| Premarin Estrogens, Conjugated | 56 | 146 | 39 | $24K |
| Imipramine Hcl Generic | 51 | 75 | 14 | $401 |
| Potassium Citrate Er Potassium Citrate | 35 | 76 | 14 | $4,210 |
| Nystatin Generic | 32 | 36 | 26 | $408 |
Brand drugs: - claims; generic drugs: 2,749 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barton H Wachs $1,465 ($1,465 in general payments such as food, travel and fees) from 19 companies. The largest payer was Agiliti Surgical, Inc. with $633.
| Company | Payments | Amount |
|---|---|---|
| Agiliti Surgical, Inc. | 8 | $633 |
| Sumitomo Pharma America, Inc. 4506.T | 9 | $198 |
| Profound Medical Corp. PROF | 1 | $107 |
| Teleflex LLC TFX | 2 | $85.95 |
| Endo USA, Inc. | 3 | $72.2 |
| Pfizer Inc. PFE | 2 | $53.78 |
| C. R. Bard, Inc. & Subsidiaries BDX | 1 | $45.61 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $32.43 |
| MIMEDX Group, Inc. MDXG | 1 | $29.28 |
| Dendreon Pharmaceuticals LLC | 1 | $27.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.